Suppressor cell induction by the anticancer drug spirogermanium
- 1 January 1987
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 9 (5) , 621-630
- https://doi.org/10.1016/0192-0561(87)90129-9
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Murine neonatal spleen contains natural T and non-T suppressor cells capable of inhibiting adult alloreactive and newborn autoreactive T-cell proliferationCellular Immunology, 1986
- Generation of suppressor cells in normal rats by treatment with spirogermanium, a novel heterocyclic anticancer drugImmunopharmacology, 1985
- The Functional and Histological Basis for Graft‐versus‐Host‐Induced ImmunosuppressionImmunological Reviews, 1985
- Murine Graft‐versus‐Host Disease across Minor Barriers: Immunosuppressive Aspects of Natural Suppressor CellsImmunological Reviews, 1985
- Identification of synergistic combinations of spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitroInvestigational New Drugs, 1984
- Rheumatoid Synovial Lymphocytes Lack Concanavalin‐A‐activated Suppressor Cell ActivityScandinavian Journal of Immunology, 1979
- Suppressor T-cell abnormality in idiopathic systemic lupus erythematosusClinical Immunology and Immunopathology, 1976
- Separation of mouse spleen cells by passage through columns of sephadex G-10Journal of Immunological Methods, 1974
- A rapid method for the isolation of functional thymus‐derived murine lymphocytesEuropean Journal of Immunology, 1973
- IMMUNIZATION OF DISSOCIATED SPLEEN CELL CULTURES FROM NORMAL MICEThe Journal of Experimental Medicine, 1967